Kawachi I, Colditz G A, Hankinson S
Channing Laboratory, Department of Medicine, Harvard Medical School, Boston, MA 02115-5899.
Contraception. 1994 Jul;50(1):1-16. doi: 10.1016/0010-7824(94)90076-0.
A risk-benefit analysis of five alternative approaches to fertility control among US women over the age of 30 was performed: tubal ligation, vasectomy, intrauterine device, barrier method (condom), and combined oral contraceptives. Taken into account were age-specific probabilities of contraceptive failure, fecundability, spontaneous abortion, reproductive mortality (ectopic pregnancy, delivery, or induced abortion), life table mortality, and mortality from specific cancer sites (ovarian, endometrial, breast, and prostate) and cardiovascular disease. Relative to women using no contraceptive precautions, the use of any method of contraception between the ages of 30 and 50 was associated with net benefit in terms of averted deaths. However, when duration of observation was extended up to age 80, we predicted an excess of about 880 deaths from prostate cancer per 100,000 users of vasectomy. Other methods continued to be associated with net benefit, ranging from 130 to 360 deaths averted per 100,000 users. It was concluded that the non-reproductive risks and benefits of contraceptive methods continue to be relevant long after the reproductive years. The balance of risks and benefits may differ in other countries with different cause-specific and life table mortality rates.
对美国30岁以上女性的五种生育控制替代方法进行了风险效益分析:输卵管结扎、输精管切除术、宫内节育器、屏障法(避孕套)和复方口服避孕药。分析考虑了特定年龄的避孕失败概率、受孕能力、自然流产、生殖死亡率(宫外孕、分娩或人工流产)、生命表死亡率以及特定癌症部位(卵巢癌、子宫内膜癌、乳腺癌和前列腺癌)和心血管疾病导致的死亡率。与未采取避孕措施的女性相比,30至50岁之间使用任何避孕方法在避免死亡方面都具有净效益。然而,当观察期延长至80岁时,我们预测每10万名输精管切除术使用者中约有880例前列腺癌死亡超额。其他方法继续具有净效益,每10万名使用者可避免130至360例死亡。研究得出结论,避孕方法的非生殖风险和效益在生育年龄之后很长时间仍然具有相关性。在其他具有不同病因特异性和生命表死亡率的国家,风险和效益的平衡可能有所不同。